These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7285015)

  • 41. Enhancement of sensitivity of fluorescence line narrowing spectrometry for detection of carcinogen-DNA adducts.
    Jankowiak R; Cooper RS; Zamzow D; Small GJ; Doskocil G; Jeffrey AM
    IARC Sci Publ; 1988; (89):372-7. PubMed ID: 3198223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The presence of a trifluoromethyl rather than a methyl substituent in the bay-region greatly decreases the DNA-binding and tumour-initiating activity of the cyclopenta[alpha]phenanthren-17-ones.
    Boyd GW; Coombs MM; Baird WM
    Carcinogenesis; 1995 Oct; 16(10):2543-7. PubMed ID: 7586164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of intestinal microflora in the metabolic activation of 6-nitrochrysene to DNA-binding derivatives in mice.
    Delclos KB; Cerniglia CE; Dooley KL; Campbell WL; Franklin W; Walker RP
    Toxicology; 1990; 60(1-2):137-50. PubMed ID: 2315936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alkylation of mammalian cell DNA, persistence of adducts, and relationship to carcinogenesis.
    Bresnick E; Eastman A
    Drug Metab Rev; 1982; 13(2):189-205. PubMed ID: 7047126
    [No Abstract]   [Full Text] [Related]  

  • 45. Potentially carcinogenic cyclopenta[a]phenanthrenes. (part)IX Characterisation of a 5,10-epoxybenzocyclodecene as a major urinary metabolite of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]-phenanthren-17-one.
    Coombs MM; Crawley FE
    J Chem Soc Perkin 1; 1974; (20):2330-5. PubMed ID: 4477762
    [No Abstract]   [Full Text] [Related]  

  • 46. The use of antibodies to detect carcinogen - DNA adducts in vivo and in vitro.
    Poirier MC
    Prog Clin Biol Res; 1983; 132B():289-98. PubMed ID: 6685294
    [No Abstract]   [Full Text] [Related]  

  • 47. Species and organ differences in DNA adduct formation and repair after treatment with 4-hydroxyaminoquinoline 1-oxide.
    Qin XS; Nakatsuru Y; Tada M; Ishikawa T
    Jpn J Cancer Res; 1990; 81(6-7):613-9. PubMed ID: 2119365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structures of the DNA adducts formed in mouse liver after administration of the proximate hepatocarcinogen 1'-hydroxyestragole.
    Phillips DH; Miller JA; Miller EC; Adams B
    Cancer Res; 1981 Jan; 41(1):176-86. PubMed ID: 6969628
    [No Abstract]   [Full Text] [Related]  

  • 49. Mass spectrometry of cyclopenta[alpha]phenanthrenes. Metabolites formed in vitro and in vivo from the carcinogen 15,16-dihydro-11-methyl-cyclopenta[alpha]phenanthren-17-one.
    Vose C; Coombs MM
    Biomed Mass Spectrom; 1977 Feb; 4(1):48-51. PubMed ID: 836943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advantages and limitations of laboratory methods for measurement of carcinogen-DNA adducts for epidemiological studies.
    Kaderlik RK; Lin DX; Lang NP; Kadlubar FF
    Toxicol Lett; 1992 Dec; 64-65 Spec No():469-75. PubMed ID: 1471199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aqueous extract of betel nut-induced adducts on pMTa4 DNA acquires stability in the presence of Na+ and K+ ions.
    Bhattacharjee C; Sharan RN
    Mol Med Rep; 2008; 1(3):435-41. PubMed ID: 21479429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 4-Hydroxyaminoquinoline 1-oxide metabolism and DNA adducts in the early stage of tumorigenesis in rats: comparison of target organ pancreas with non-target organ liver.
    Denda A; Mori Y; Yokose Y; Uchida K; Murata Y; Makino T; Tsutsumi M; Konishi Y
    Chem Biol Interact; 1985 Dec; 56(2-3):125-43. PubMed ID: 3935337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of dihydrodiol conformation on the metabolic activation of cyclopenta[a]phenanthrenes.
    Boyd GW; Ioannides C; Coombs MM
    Toxicol Lett; 1995 Jan; 75(1-3):93-100. PubMed ID: 7863542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair.
    Harris CC
    Carcinogenesis; 1989 Sep; 10(9):1563-6. PubMed ID: 2670300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of partial hepatectomy on the formation and elimination of 3-methyldibenzo(c,g)carbazole and 5,9-dimethyldibenzo(c,g)carbazole-DNA adducts in mouse liver.
    Szafarz D; Valero D; Perin F; Bornecque C
    Biol Cell; 1990; 68(2):91-4. PubMed ID: 2357492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accumulation and elimination of macromolecular lesions in susceptible and non-susceptible rat tissues after repeated administration of trans-4-acetylaminostilbene.
    Hilpert D; Neumann HG
    Chem Biol Interact; 1985 Jun; 54(1):85-95. PubMed ID: 2410150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carcinogen binding to DNA.
    Straub KM; Burlingame AL
    Biomed Mass Spectrom; 1981 Sep; 8(9):431-5. PubMed ID: 7306680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-carcinogenicity of promoting agents.
    Vose CW; Coombs MM; Bhatt TS
    Carcinogenesis; 1981; 2(7):687-9. PubMed ID: 7273348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical detection of 4-hydroxyaminoquinoline 1-oxide-DNA adducts in mouse tissues in vivo.
    Nakagawa K; Tada M; Morita T; Utsunomiya J; Ishikawa T
    J Natl Cancer Inst; 1988 May; 80(6):419-25. PubMed ID: 3130487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunocytochemical analysis of carcinogen-DNA adducts in normal and preneoplastic tissues.
    Scherer E; Bax H; van Benthem J
    Prog Histochem Cytochem; 1991; 23(1-4):77-83. PubMed ID: 1947170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.